SCHEMBL14720718

SCHEMBL14720718

COC1CCN(S(=O)(=O)c2ccc(C=C3CCN(C4CCC4)CC3)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.51
ALDH1A1 P00352 7/20 0.50
KDM4E B2RXH2 4/20 0.50
GAA P10253 2/20 0.50
CYP2D6 P10635 2/20 0.50
CYP2C19 P33261 1/20 0.50
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPK1 P28482 1/20 0.44
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 1/20 0.44
HRH3 Q9Y5N1 4/20 0.44
KCNH2 Q12809 2/20 0.44
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720578 0.91 KDM4E (0.47) HSD11B1ALDH1A1KDM4EGAACYP2D6
SCHEMBL14720887 0.83 POLB (0.52) ALDH1A1KDM4EGAAMEN1KMT2A
SCHEMBL14731080 0.81 HSD11B1 (0.47) HSD11B1ALDH1A1GAAMEN1KMT2A
SCHEMBL23884718 0.79 HSD11B1 (0.60) HSD11B1ALDH1A1CYP2D6CYP2C19MEN1
SCHEMBL14720643 0.77 OPRM1 (0.41) KMT2ASMN1; SMN2HRH3
SCHEMBL14720768 0.76 KCNH2 (0.44) ALDH1A1KDM4EGAACYP2D6CYP2C19
SCHEMBL14720491 0.75 HRH3 (0.45) ALDH1A1KDM4EGAACYP2D6CYP2C19
SCHEMBL14720492 0.74 HRH3 (0.34) CYP2D6HRH3
SCHEMBL14720519 0.74 HRH3 (0.34) HRH3
SCHEMBL14721408 0.74 HRH3 (0.34) CYP2D6HRH3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed